Model Number 37612 |
Device Problems
Use of Device Problem (1670); Charging Problem (2892)
|
Patient Problems
Cellulitis (1768); Pocket Erosion (2013); Tingling (2171)
|
Event Date 03/04/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
The main device described in section is not approved under pma/510k # h020007 for the described indication: dystonia (product code: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a patient with an implantable neurostimulator (ins) for dystonia.It was reported that the patient was having a revision on monday to move the ins from the chest to their waistline because they've been having a lot of problems in the current location.They don't have a lot of body fat in that area, really bony, and experiencing a prickly feeling when recharging.The healthcare provider (hcp) indicated there was cellulitis and skin thinning over the implant after the ins replacement recently in the past 6 months.The patient had trouble positioning the antenna over the tender cellulitic area.When asked the cause, the hcp indicated they thought it was the antenna over cellulitis, and possibly some reception of warmth when recharging.No further complications were reported or anticipated with this event.
|
|
Manufacturer Narrative
|
(b)(4) applies to the event and was excluded from the previous report in error.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
No additional information was received.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|